The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., & Wiley, D. C. (1987) · Nature · doi:10.1038/329512a0 · Cited by 2,377
ZINKERNAGEL, R. M., & DOHERTY, P. C. (1974) · Nature · doi:10.1038/248701a0 · Cited by 2,095
Townsend, A. (1986) · Cell · doi:10.1016/0092-8674(86)90019-x · Cited by 1,699
Introduction of soluble protein into the class I pathway of antigen processing and presentation
Moore, M. W., Carbone, F. R., & Bevan, M. J. (1988) · Cell · doi:10.1016/s0092-8674(88)91043-4 · Cited by 1,092
Covalent lipoprotein from the outer membrane of Escherichia coli
Braun, V. (1975) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(75)90013-1 · Cited by 580
Immunology: The ins and outs of antigen processing and presentations
Germain, R. N. (1986) · Nature · doi:10.1038/322687a0 · Cited by 496
Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.
Carbone, F. R., & Bevan, M. J. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.3.603 · Cited by 219
Class discrimination in the world of immunology
Bevan, M. J. (1987) · Nature · doi:10.1038/325192b0 · Cited by 211
Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides.
Carbone, F. R., Moore, M. W., Sheil, J. M., & Bevan, M. J. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.6.1767 · Cited by 186
Cytotoxic T lymphocytes against a soluble protein
Staerz, U. D., Karasuyama, H., & Garner, A. M. (1987) · Nature · doi:10.1038/329449a0 · Cited by 171
Cited by
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein
Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki, V. J., Gromkowski, S. H., Deck, R. R., DeWitt, C. M., Friedman, A., et al. (1993) · Science · doi:10.1126/science.8456302 · Cited by 2,318
Rosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Dudley, M. E., Schwarz, S. L., Spiess, P. J., et al. (1998) · Nature Medicine · doi:10.1038/nm0398-321 · Cited by 1,784
Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells
Rötzschke, O., Falk, K., Deres, K., Schild, H., Norda, M., Metzger, J., Jung, G., & Rammensee, H.-G. (1990) · Nature · doi:10.1038/348252a0 · Cited by 769
Self-citationMechanisms of Action of Adjuvants
Awate, S., Babiuk, L. A., & Mutwiri, G. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00114 · Cited by 732
Vaccines for established cancer: overcoming the challenges posed by immune evasion
van der Burg, S. H., Arens, R., Ossendorp, F., van Hall, T., & Melief, C. J. M. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.16 · Cited by 709
Adjuvants—a classification and review of their modes of action
Cox, J. C., & Coulter, A. R. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00183-1 · Cited by 682
Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A., & Boon, T. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.5.1453 · Cited by 679
Diagnosis and Management of Human Cytomegalovirus Infection in the Mother, Fetus, and Newborn Infant
Revello, M. G., & Gerna, G. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.4.680-715.2002 · Cited by 618
Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines
Melief, C. J. M., & van der Burg, S. H. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2373 · Cited by 594
“Similar to what was observed after physical linking of T H and Tc peptides, TLR–peptide conjugate-induced T-cell responses that vastly exceed the responses observed following the injection of the mixed component”
ResultAlexander, J., Sidney, J., Southwood, S., Ruppert, J., Oseroff, C., Maewal, A., Snoke, K., Serra, H. M., Kubo, R. T., Sette, A., et al. (1994) · Immunity · doi:10.1016/s1074-7613(94)80017-0 · Cited by 523
Steinhagen, F., Kinjo, T., Bode, C., & Klinman, D. M. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.08.002 · Cited by 501
Induction of virus‐specific cytotoxic T lymphocytes in vivo by liposome‐entrapped mRNA
Martinon, F., Krishnan, S., Lenzen, G., Magné, R., Gomard, E., Guillet, J., Lévy, J., & Meulien, P. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230749 · Cited by 473
Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes
Pamer, E. G., Harty, J. T., & Bevan, M. J. (1991) · Nature · doi:10.1038/353852a0 · Cited by 417
Two tyrosinase nonapeptides recognized on HLA‐A2 melanomas by autologous cytolytic T lymphocytes
Wölfel, T., Van Pel, A., Brichard, V., Schneider, J., Seliger, B., Zum Büschenfelde, K. M., & Boon, T. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240340 · Cited by 411
Mühlradt, P. F., Kieß, M., Meyer, H., Süßmuth, R., & Jung, G. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.11.1951 · Cited by 396
Self-citationTowards the Chemical Synthesis of Proteins
Bayer, E. (1991) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199101133 · Cited by 347
McLaughlin‐Taylor, E., Pande, H., Forman, S. J., Tanamachi, B., Li, C., Zaia, J. A., Greenberg, P. D., & Riddell, S. R. (1994) · Journal of Medical Virology · doi:10.1002/jmv.1890430119 · Cited by 342
Vitiello, A., Ishioka, G., Grey, H. M., Rose, R., Farness, P., LaFond, R., Yuan, L., Chisari, F. V., Furze, J., & Bartholomeuz, R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117662 · Cited by 334
Kast, W. M., Roux, L., Curren, J., Blom, H. J., Voordouw, A. C., Meloen, R. H., Kolakofsky, D., & Melief, C. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2283 · Cited by 326
Celis, E., Tsai, V, Crimi, C., DeMars, R., Wentworth, P. A., Chesnut, R. W., Grey, H. M., Sette, A., & Serra, H. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2105 · Cited by 306
Multiple Peptide Synthesis Methods and Their Applications. New Synthetic Methods (87)
Jung, G., & Beck‐Sickinger, A. G. (1992) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199203673 · Cited by 292
Self-citationLipopeptides: from self-assembly to bioactivity
Hamley, I. W. (2015) · Chemical Communications · doi:10.1039/c5cc01535a · Cited by 290
Tumor Eradication by Adoptive Transfer of Cytototic T Lymphocytes
(1992) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60294-8 · Cited by 275
Bhardwaj, N., Bender, A., Gonzalez, N., Bui, L. K., Garrett, M. C., & Steinman, R. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117399 · Cited by 269
Stover, C. K., Bansal, G. P., Hanson, M. S., Burlein, J. E., Palaszynski, S. R., Young, J. F., Koenig, S., Young, D. B., Sadziene, A., & Barbour, A. G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.1.197 · Cited by 267
MHC Class I–Restricted CTL Responses to Exogenous Antigens
Jondal, M., Schirmbeck, R., & Reimann, J. (1996) · Immunity · doi:10.1016/s1074-7613(00)80255-1 · Cited by 253
Recent progress in adjuvant discovery for peptide-based subunit vaccines
Azmi, F., Ahmad Fuaad, A. A. H., Skwarczynski, M., & Toth, I. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.27332 · Cited by 239
“Jackson and colleagues have demonstrated that a T cell peptide epitope derived from influenza virus when covalently linked to Pam 3 Cys stimulated a T cell mediated immune response.(137) Although proven to enhance the immunogenicity of peptide antigens, lipopeptides comprised of Pam 3 Cys have usually poor water-solub…”
BackgroundJackson, D. C., Lau, Y. F., Le, T., Suhrbier, A., Deliyannis, G., Cheers, C., Smith, C., Zeng, W., & Brown, L. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406740101 · Cited by 236
The Peptide Vaccine of the Future
Nelde, A., Rammensee, H.-G., & Walz, J. S. (2021) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r120.002309 · Cited by 205
Self-citationM-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B
Gupta, P. N., Khatri, K., Goyal, A. K., Mishra, N., & Vyas, S. P. (2007) · Journal of Drug Targeting · doi:10.1080/10611860701637982 · Cited by 136
Zhou, X., Berglund, P., Zhao, H., Liljeström, P., & Jondal, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.3009 · Cited by 115
Biosurfactants: A COVID-19 Perspective
Smith, M. L., Gandolfi, S., Coshall, P. M., & Rahman, P. K. S. M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01341 · Cited by 96
Zaman, M., & Toth, I. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00318 · Cited by 90
Zeng, W., Horrocks, K. J., Tan, A. C. L., Wong, C. Y., Chua, B. Y., & Jackson, D. C. (2020) · Vaccine · doi:10.1016/j.vaccine.2019.10.055 · Cited by 4
Metadata
- Authors
- Deres, K., Schild, H., Wiesmüller, K.-H., Jung, G., & Rammensee, H.-G.
- Venue
- Nature
- Published
- 1989-11-30
- Volume
- 342
- Issue
- 6249
- Pages
- 561-564
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1984512389
- Cited by
- 631
- References
- 18
- FWCI
- 19.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.